Teresa Santos

Prof. Dr. Teresa Santos

Universidade de Coimbra, Coimbra, Portugal
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
SHSamantha Hansford
Samantha Hansford
PKPardeep Kaurah
Pardeep Kaurah
HLHector Li-Chang
Hector Li-Chang
MWMichelle Woo
Michelle Woo
JSJanine Senz
Janine Senz
DHDavid Huntsman
David Huntsman
Quiz Ref ID Gastric cancer (GC) is the third most common cause of cancer-related mortality worldwide.1 The 2 major subtypes, diffuse GC (DGC) and intestinal-type GC, are distinguished by molecular, epidemiologic, and morphologic features.2 Although GC is usually sporadic, familial aggregation occurs in approximately 10% of cases.3,4 Quiz Ref ID Clinically defined hereditary DGC (HDGC) (OMIM #137215) is characterized by early-onset, multigenerational DGC and lobular breast cancer. Clinical criteria for this entity was established by the International Gastric Cancer Linkage Consortium (IGCLC) (Table 1).5,6 Approximately 40% of HDGC families have germline mutations in CDH1 (E-cadherin) (Ensembl ENSG00000039068; OMIM *192090), and over 100 different pathogenic germline mutations are reported across multiple ethnicities (eTable 1 in the Supplement).

1 March 2006 in Fertility and Sterility
Verified
Journal Article
Closed access
TSTeresa Santos
Teresa Santos
SSShahy El Shourbagy
Shahy El Shourbagy
JJJustin C. St. John
Justin C. St. John

20 November 2018 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
AAAntoinette Catherine Anazodo
Antoinette Catherine Anazodo
PLPaula Laws
Paula Laws
SLShanna Logan
Shanna Logan
CSCarla Saunders
Carla Saunders
JTJo Travaglia
Jo Travaglia
ESElizabeth Sullivan
Elizabeth Sullivan
Fertility preservation (FP) is an important quality of life issue for cancer survivors of reproductive age. Despite the existence of broad international guidelines, the delivery of oncofertility care, particularly amongst paediatric, adolescent and young adult patients, remains a challenge for healthcare professionals (HCPs). The quality of oncofertility care is variable and the uptake and utilization of FP remains low. Available guidelines fall short in providing adequate detail on how oncofertility models of care (MOC) allow for the real-world application of guidelines by HCPs. The aim of this study was to systematically review the literature on the components of oncofertility care as defined by patient and clinician representatives, and identify the barriers, facilitators and challenges, so as to improve the implementation of oncofertility services. A systematic scoping review was conducted on oncofertility MOC literature published in English between 2007 and 2016, relating to 10 domains of care identified through consumer research: communication, oncofertility decision aids, age-appropriate care, referral pathways, documentation, training, supportive care during treatment, reproductive care after cancer treatment, psychosocial support and ethical practice of oncofertility care. A wide range of electronic databases (CINAHL, Embase, PsycINFO, PubMed, AEIPT, Education Research Complete, ProQuest and VOCED) were searched in order to synthesize the evidence around delivery of oncofertility care. Related citations and reference lists were searched. The review was undertaken following registration (International prospective register of systematic reviews (PROSPERO) registration number CRD42017055837) and guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A total of 846 potentially relevant studies were identified after the removal of duplicates. All titles and abstracts were screened by a single reviewer and the final 147 papers were screened by two reviewers. Ten papers on established MOC were identified amongst the included papers. Data were extracted from each paper and quality scores were then summarized in the oncofertility MOC summary matrix. The results identified a number of themes for improving MOC in each domain, which included: the importance of patients receiving communication that is of a higher quality and in different formats on their fertility risk and FP options; improving provision of oncofertility care in a timely manner; improving access to age-appropriate care; defining the role and scope of practice of all HCPs; and improving communication between different HCPs. Different forms of decision aids were found useful for assisting patients to understand FP options and weigh up choices. This analysis identifies core components for delivery of oncofertility MOC. The provision of oncofertility services requires planning to ensure services have safe and reliable referral pathways and that they are age-appropriate and include medical and psychological oncofertility care into the survivorship period. In order for this to happen, collaboration needs to occur between clinicians, allied HCPs and executives within paediatric and adult hospitals, as well as fertility clinics across both public and private services. Training of both cancer and non-cancer HCPs is needed to improve the knowledge of HCPs, the quality of care provided and the confidence of HCPs with these consultations.

23 March 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAna Paula SOUSA
Ana Paula SOUSA
AAAlexandra Amaral
Alexandra Amaral
MBMarta Baptista
Marta Baptista
RTRenata Tavares
Renata Tavares
PCPedro Caballero Campo
Pedro Caballero Campo
Joao Ramalho-SantosJoao Ramalho-Santos
Joao Ramalho-Santos
Human sperm samples are very heterogeneous and include a low amount of truly functional gametes. Distinct strategies have been developed to characterize and isolate this specific subpopulation. In this study we have used fluorescence microscopy and fluorescence-activated cell sorting to determine if mitochondrial function, as assessed using mitochondrial-sensitive probes, could be employed as a criterion to obtain more functional sperm from a given ejaculate. We first determined that mitochondrial activity correlated with the quality of distinct human samples, from healthy donors to patients with decreased semen quality. Furthermore, using fluorescence-activated cell sorting to separate sperm with active and inactive mitochondria we found that this was also true within samples. Indeed, sperm with active mitochondria defined a more functional subpopulation, which contained more capacitated and acrosome intact cells, sperm with lower chromatin damage, and, crucially, sperm more able to decondense and participate in early development using both chemical induction and injection into mature bovine oocytes. Furthermore, cell sorting using mitochondrial activity produced a more functional sperm subpopulation than classic swim-up, both in terms of improvement in a variety of functional sperm parameters and in statistical significance. In conclusion, whatever the true biological role of sperm mitochondria in fertilization, mitochondrial activity is a clear hallmark of human sperm functionality.

1 April 2016 in Journal of Global Oncology
Verified
Journal Article
Open access
LALauren M. Ataman
Lauren M. Ataman
JRJhenifer K. Rodrigues
Jhenifer K. Rodrigues
RMRicardo M. Marinho
Ricardo M. Marinho
JCJoão P.J. Caetano
João P.J. Caetano
MCMaurício B. Chehin
Maurício B. Chehin
TWTeresa K. Woodruff
Teresa K. Woodruff
Fertility preservation in the cancer setting, known as oncofertility, is a field that requires cross-disciplinary interaction between physicians, basic scientists, clinical researchers, ethicists, ...

1 June 2019 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
Marie-Madeleine DolmansMarie-Madeleine Dolmans
Marie-Madeleine Dolmans
Matteo LambertiniMatteo Lambertini
Matteo Lambertini
KMKirsten Tryde Macklon
Kirsten Tryde Macklon
TSTeresa Santos
Teresa Santos
ARAna Ruiz-Casado
Ana Ruiz-Casado
AGAriane Germeyer
Ariane Germeyer